Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$8.24 - $12.97 $1,417 - $2,230
-172 Reduced 2.9%
5,754 $48,000
Q2 2023

Aug 11, 2023

BUY
$9.99 - $18.27 $30,289 - $55,394
3,032 Added 104.77%
5,926 $74,000
Q1 2023

May 12, 2023

SELL
$15.0 - $22.76 $570 - $864
-38 Reduced 1.3%
2,894 $48,000
Q4 2022

Feb 10, 2023

BUY
$14.16 - $24.02 $41,517 - $70,426
2,932 New
2,932 $44,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $1.09B
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Ci Investments Inc. Portfolio

Follow Ci Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.